INOVIO to Present at Upcoming Scientific Conference
INOVIO (NASDAQ:INO), a biotechnology company specializing in DNA medicines, has announced its participation in the upcoming Orphan Drug Summit in Boston, Massachusetts. The company will present on July 16 at 4:30 PM ET, focusing on their DMAb Technology and its transformational potential in rare disease treatment.
The presentation will explore the capabilities of next generation DNA medicine technology in addressing rare diseases, as part of a conference that brings together industry leaders and innovators to discuss technological and manufacturing advancements in the rare disease space.
INOVIO (NASDAQ:INO), un'azienda biotecnologica specializzata in medicinali a base di DNA, ha annunciato la sua partecipazione al prossimo Orphan Drug Summit che si terr脿 a Boston, Massachusetts. L'azienda presenter脿 il 16 luglio alle 16:30 ET, concentrandosi sulla loro tecnologia DMAb e sul suo potenziale rivoluzionario nel trattamento delle malattie rare.
La presentazione esplorer脿 le capacit脿 della tecnologia di medicina a base di DNA di nuova generazione nel trattamento delle malattie rare, nell'ambito di una conferenza che riunisce leader del settore e innovatori per discutere i progressi tecnologici e produttivi nel campo delle malattie rare.
INOVIO (NASDAQ:INO), una empresa biotecnol贸gica especializada en medicamentos de ADN, ha anunciado su participaci贸n en la pr贸xima Orphan Drug Summit en Boston, Massachusetts. La compa帽铆a presentar谩 el 16 de julio a las 4:30 PM ET, enfoc谩ndose en su tecnolog铆a DMAb y su potencial transformador en el tratamiento de enfermedades raras.
La presentaci贸n explorar谩 las capacidades de la tecnolog铆a de medicina de ADN de pr贸xima generaci贸n para abordar enfermedades raras, como parte de una conferencia que re煤ne a l铆deres e innovadores de la industria para discutir avances tecnol贸gicos y de fabricaci贸n en el 谩mbito de las enfermedades raras.
INOVIO (NASDAQ:INO)電� DNA 鞚橃暯頀堨潉 鞝勲鞙茧 頃橂姅 靸濍獏瓿淀暀 須岇偓搿�, 毵れ偓於旍劯旄犾＜ 氤挫姢韯挫棎靹� 鞐措Μ電� Orphan Drug Summit鞐� 彀胳棳頃� 鞓堨爼鞛勳潉 氚滍憸頄堨姷雼堧嫟. 須岇偓電� 7鞗� 16鞚� 鞓ろ泟 4鞁� 30攵�(霃欕秬鞁滉皠)鞐� DMAb 旮办垹瓿� 頋穩歆堩櫂 旃橂鞐� 鞛堨柎 攴� 氤�順侅爜 鞛犾灛霠レ棎 雽�頃� 氚滍憸頃� 鞓堨爼鞛呺媹雼�.
鞚措矆 氚滍憸鞐愳劀電� 彀劯雽� DNA 鞚橃暯 旮办垹鞚� 頋穩歆堩櫂 旃橂鞐� 鞏措柣瓴� 旮办棳頃� 靾� 鞛堧姅歆�毳� 韮愱惮頃� 鞓堨爼鞚措┌, 鞚� 旎嵓霟办姢電� 頋穩歆堩櫂 攵勳暭鞚� 旮办垹 氚� 鞝滌“ 順侅嫚鞚� 雲检潣頃橁赴 鞙勴暣 鞐呹硠 毽崝鞕� 順侅嫚臧�霌れ澊 氇澊電� 鞛愲Μ鞛呺媹雼�.
INOVIO (NASDAQ:INO), une entreprise de biotechnologie sp茅cialis茅e dans les m茅dicaments 脿 base d'ADN, a annonc茅 sa participation au prochain Orphan Drug Summit 脿 Boston, Massachusetts. La soci茅t茅 pr茅sentera le 16 juillet 脿 16h30 ET, en mettant l'accent sur leur technologie DMAb et son potentiel transformateur dans le traitement des maladies rares.
La pr茅sentation explorera les capacit茅s de la technologie de m茅decine 脿 base d'ADN de nouvelle g茅n茅ration pour traiter les maladies rares, dans le cadre d'une conf茅rence r茅unissant des leaders et des innovateurs de l'industrie pour discuter des avanc茅es technologiques et de fabrication dans le domaine des maladies rares.
INOVIO (NASDAQ:INO), ein Biotechnologieunternehmen, das sich auf DNA-Medikamente spezialisiert hat, hat seine Teilnahme am bevorstehenden Orphan Drug Summit in Boston, Massachusetts, angek眉ndigt. Das Unternehmen wird am 16. Juli um 16:30 Uhr ET pr盲sentieren und dabei den Fokus auf ihre DMAb-Technologie und deren revolution盲res Potenzial in der Behandlung seltener Krankheiten legen.
Die Pr盲sentation wird die F盲higkeiten der n盲chsten Generation von DNA-Medizintechnologie zur Behandlung seltener Krankheiten beleuchten, im Rahmen einer Konferenz, die Branchenf眉hrer und Innovatoren zusammenbringt, um technologische und produktionstechnische Fortschritte im Bereich seltener Krankheiten zu diskutieren.
- None.
- None.
Orphan Drug Summit
Date: July 16
Time: 4:30-4:55pm ET
Presentation: DMAb Technology: The Transformational Potential of Next Gen DNA Medicine in Rare Disease
About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit .
Contacts
Media: Jennie Willson, (267) 429-8567, [email protected]
Investors: Peter Vozzo - ICR Healthcare, (443) 213-0505,听[email protected]
听
View original content to download multimedia:
SOURCE INOVIO Pharmaceuticals, Inc.
FAQ
When is INOVIO (INO) presenting at the Orphan Drug Summit 2025?
What will INOVIO present at the Orphan Drug Summit 2025?
Where can I watch INOVIO's Orphan Drug Summit 2025 presentation?
What is INOVIO's main business focus?
